Source Job

• Develop and maintain high-impact investor relations and corporate communications materials, including press releases, earnings scripts, and presentations.
• Support analyst and institutional investor engagement and help advance investor targeting strategies.
• Partner cross-functionally with Finance, Legal, Commercial, and other teams to ensure accurate and compliant communications.

Iovance Biotherapeutics is a biotechnology company focused on developing tumor infiltrating lymphocyte (TIL) therapy for cancer. The company is a global leader in cell therapy innovation and fosters a culture of continuous innovation and collaboration.

• Develop and execute a comprehensive investor relations strategy and create compelling investor materials.
• Build and maintain relationships with institutional and strategic investors, serving as a primary point of contact.
• Partner with finance to distill complex metrics into narratives and lay groundwork for IPO readiness.

Cohere is a security-first enterprise AI company building cutting-edge foundation models and products for real-world business problems. They are a global team of researchers, engineers, and designers with offices in Toronto, San Francisco, London, New York, and more.

• Oversee strategic and operational execution of clinical trials, leading cross-functional teams and managing vendor selection.
• Direct clinical trial budgets, risk mitigation, and provide technical input into key clinical documents.
• Mentor staff and foster strong team relationships in a dynamic organization.

Jade Biosciences is a clinical-stage biotechnology company developing best-in-class therapies for autoimmune diseases. The company was launched based on assets licensed from Paragon Therapeutics and has a growing pipeline.